Conserved hydrogen bonds and water molecules in MDR HIV-1 protease substrate complexes
-
Add time:09/09/2019 Source:sciencedirect.com
The success of highly active antiretroviral therapy (HAART) in anti-HIV therapy is severely compromised by the rapidly developing drug resistance. HIV-1 protease inhibitors, part of HAART, are losing their potency and efficacy in inhibiting the target. Multi-drug resistant (MDR) 769 HIV-1 protease (resistant mutations at residues 10, 36, 46, 54, 62, 63, 71, 82, 84, 90) was selected for the present study to understand the binding to its natural substrates. The nine crystal structures of MDR769 HIV-1 protease substrate hepta-peptide complexes were analyzed in order to reveal the conserved structural elements for the purpose of drug design against MDR HIV-1 protease. Our structural studies demonstrated that highly conserved hydrogen bonds between the protease and substrate peptides, together with the conserved crystallographic water molecules, played a crucial role in the substrate recognition, substrate stabilization and protease stabilization. In addition, the absence of the key flap-ligand bridging water molecule might imply a different catalytic mechanism of MDR769 HIV-1 protease compared to that of wild type (WT) HIV-1 protease.
We also recommend Trading Suppliers and Manufacturers of HIV PROTEASE SUBSTRATE III (cas 138608-20-5). Pls Click Website Link as below: cas 138608-20-5 suppliers
Prev:A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening
Next:Research paperEvolution of inhibitor-resistant natural mutant forms of HIV-1 protease probed by pre-steady state kinetic analysis) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short communicationYeast cells as a tool for analysis of HIV-1 protease susceptibility to protease inhibitors, a comparative study09/26/2019
- Expedient screening for HIV-1 protease inhibitors using a simplified immunochromatographic assay09/25/2019
- Review articleDesign strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties09/24/2019
- Research paperEvolution of inhibitor-resistant natural mutant forms of HIV-1 protease probed by pre-steady state kinetic analysis09/10/2019
- A recombinant fusion protein-based, fluorescent protease assay for high throughput-compatible substrate screening09/08/2019
- HIV-1 protease and reverse transcriptase inhibition by tiger milk mushroom (Lignosus rhinocerus) sclerotium extracts: In vitro and in silico studies09/07/2019
- On the relationship between docking scores and protein conformational changes in HIV-1 protease09/06/2019
- Semi-quantification of HIV-1 protease inhibitor concentrations in clinical samples of HIV-infected patients using a gold nanoparticle-based immunochromatographic assay09/05/2019
- Research paperHIV-1 protease substrate-groove: Role in substrate recognition and inhibitor resistance09/04/2019


